You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 亞盛醫藥-B兩日累漲15% Bcl-2抑制劑APG-2575再下一城
格隆匯 04-08 15:56
格隆匯4月8日丨亞盛醫藥-B(06855.HK)延續昨日升勢,兩日累漲15%,近乎抹平此前跌幅。現報26港元,漲4%,最新總市值53.4億港元。亞盛醫藥-B7日宣佈公司重要在研產品APG-2575再下一城,其在中國又獲批一項Ib/II期臨牀試驗批件。此前,APG-2575已在美國、澳大利亞和中國進行單藥I期臨牀試驗,並獲得令人欣喜的安全性和有效性數據。此外,從2019年報中獲悉,在強有力的研發投入下,公司當期研發管線取得全面進展,核心候選藥物HQP1351商業化臨近。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account